Studying human respiratory disease in animals - Role of induced and naturally occurring models

Journal of Pathology

Volumn 238, Issue 2, 2016, Pages 220-232

  Williams, Kurt ^a   Roman, Jesse ^b  

^a MICHIGAN STATE UNIVERSITY   (United States)

^b VETERANS AFFAIRS MEDICAL CENTER   (United States)

Author keywords

animal models; asthma; lung; pulmonary disease; pulmonary fibrosis

Indexed keywords

BIOLOGICAL MARKER;

AIRWAY OBSTRUCTION; ASTHMA; BRONCHITIS; CAT; DISEASE COURSE; DOG; DOG DISEASE; DOMESTIC ANIMAL; DONKEY; EQUIDAE; HORSE; HUMAN; LUNG FIBROSIS; NONHUMAN; PNEUMONIA; PRIORITY JOURNAL; RECURRENT DISEASE; RESPIRATORY TRACT DISEASE; REVIEW; ANIMAL; ANIMAL DISEASES; DISEASE MODEL; MOUSE; RESPIRATORY TRACT DISEASES; VETERINARY;

ANIMAL DISEASES; ANIMALS; ANIMALS, DOMESTIC; CATS; DISEASE MODELS, ANIMAL; DOGS; EQUIDAE; HUMANS; MICE; RESPIRATORY TRACT DISEASES;

EID: 84951299516     PISSN: 00223417     EISSN: 10969896     Source Type: Journal    
DOI: 10.1002/path.4658     Document Type: Review

References (118)

1. Grimshaw GM, Stanton A,. Tobacco cessation interventions for young people. Cochrane Database Syst Rev 2006; 8: CD003289.
2. Diaz-Guzman E, Mannino DM,. Epidemiology and prevalence of chronic obstructive pulmonary disease. Clin Chest Med 2014; 35: 7-16.
3. Gordon SB, Bruce NG, Grigg J, et al., Respiratory risks from household air pollution in low and middle income countries. Lancet Respir Med 2014; 2: 823-860.
4. Celedon JC, Roman J, Schraufnagel DE, et al., Respiratory health equality in the United States. The American Thoracic Society perspective. Ann Am Thorac Soc 2014; 11: 473-479.
5. Ericsson AC, Crim MJ, Franklin CL,. A brief history of animal modeling. Mo Med 2013; 110: 201-205.
6. Lennox JG, (Translator). Aristotle: On the Parts of Animals (1st edn). Oxford University Press: Oxford, 2001; 52-54.
7. Gotthelf A., Darwin on Aristotle. J History Biol 1999; 32: 3-30.
8. Hau J., Animal models of human disease. In Sourcebook of Models for Biomedical Research, Conn PM, (ed). Humana Press: Totowa, NJ, 2008; 3-8.
9. Kumar RK, Herbert C, Foster PS,. The 'classical' ovalbumin challenge model of asthma in mice. Curr Drug Targets 2008; 9: 485-494.
10. Thrall RS, Vogel SN, Evans R, et al., Role of tumor necrosis factor-alpha in the spontaneous development of pulmonary fibrosis in viable motheaten mutant mice. Am J Pathol 1997; 151: 1303-1310.
11. Yan Z, Stewart ZA, Sinn PL, et al., Ferret and pig models of cystic fibrosis: prospects and promise for gene therapy. Hum Gene Ther Clin Dev 2015; 26: 38-49.
12. Sanchez-Sampedro L, Perdiguero B, Mejias-Perez E, et al., The evolution of poxvirus vaccines. Viruses 2015; 7: 1726-1803.
13. Rubin H., The early history of tumor virology: Rous, RIF, and RAV. Proc Natl Acad Sci U S A 2011; 108: 14389-14396.
14. Hunfeld KP, Hildebrandt A, Gray JS,. Babesiosis: recent insights into an ancient disease. Int J Parasitol 2008; 38: 1219-1237.
15. Safransky RJ,. The Morrill Acts. In Encyclopedia of Law and Higher Education, Russo CJ, (ed). SAGE Publications: Thousand Oaks, CA, 2010; 317-319.
16. Enserink M., Medicine. Initiative aims to merge animal and human health science to benefit both. Science 2007; 316: 1553.
17. Cardiff RD, Ward JM, Barthold SW,. 'One medicine-one pathology': are veterinary and human pathology prepared? Lab Invest 2008; 88: 18-26.
18. Zinsstag J, Schelling E, Waltner-Toews D, et al., From 'one medicine' to 'one health' and systemic approaches to health and well-being. Prev Vet Med 2011; 101: 148-156.
19. van Helden PD, van Helden LS, Hoal EG,. One world, one health. Humans, animals and the environment are inextricably linked-a fact that needs to be remembered and exploited in our modern approach to health. EMBO Rep 2013; 14: 497-501.
20. Gibbs EP,. The evolution of One Health: a decade of progress and challenges for the future. Vet Rec 2014; 174: 85-91.
21. Serre D, Paabo S,. Evidence for gradients of human genetic diversity within and among continents. Genome Res 2004; 14: 1679-1685.
22. Burri PH,. Structural aspects of postnatal lung development-alveolar formation and growth. Biol Neonate 2006; 89: 313-322.
23. Grubb BR, Boucher RC,. Pathophysiology of gene-targeted mouse models for cystic fibrosis. Physiol Rev 1999; 79: S193-S214.
24. Peake JL, Pinkerton KE., Gross and subgross anatomy of lungs, pleura, connective tissue septa, distal airways, and structural units. In Comparative Biology of the Normal Lung (2nd edn), Parent RA, (ed). Academic Press: London, 2015; 21.
25. Schwartz LW, Dungworth DL, Mustafa MG, et al., Pulmonary responses of rats to ambient levels of ozone: effects of 7-day intermittent or continuous exposure. Lab Invest 1976; 34: 565-578.
26. Tyler WS, Tyler NK, Last JA, et al., Comparison of daily and seasonal exposures of young monkeys to ozone. Toxicology 1988; 50: 131-144.
27. Niewoehner DE, Kleinerman J, Rice DB,. Pathologic changes in the peripheral airways of young cigarette smokers. N Engl J Med 1974; 291: 755-758.
28. Norris Reinero CR, Decile KC, Berghaus RD, et al., An experimental model of allergic asthma in cats sensitized to house dust mite or bermuda grass allergen. Int Arch Allergy Immunol 2004; 135: 117-131.
29. Williams KJ, Malarkey D, Cohn L, et al., Identification of spontaneous feline idiopathic pulmonary fibrosis: morphology and ultrastructural evidence for a type II pneumocyte defect. Chest 2004; 125: 2278-2288.
30. Rennard SI, Drummond MB,. Early chronic obstructive pulmonary disease: definition, assessment, and prevention. Lancet 2015; 385: 1778-1788.
31. Wright JL, Cosio M, Churg A,. Animal models of chronic obstructive pulmonary disease. Am J Physiol Lung Cell Mol Physiol 2008; 295: L1-L15.
32. Bartalesi B, Cavarra E, Fineschi S, et al., Different lung responses to cigarette smoke in two strains of mice sensitive to oxidants. Eur Respir J 2005; 25: 15-22.
33. March TH, Wilder JA, Esparza DC, et al., Modulators of cigarette smoke-induced pulmonary emphysema in A/J mice. Toxicol Sci 2006; 92: 545-559.
34. Janoff A, White R, Carp H, et al., Lung injury induced by leukocytic proteases. Am J Pathol 1979; 97: 111-136.
35. Sahebjami H., Effects of postnatal starvation and refeeding on rat lungs during adulthood. Am Rev Respir Dis 1986; 133: 769-772.
36. D'Armiento J, Dalal SS, Okada Y, et al,. Collagenase expression in the lungs of transgenic mice causes pulmonary emphysema. Cell 1992; 71: 955-961.
37. Mizgerd JP, Skerrett SJ,. Animal models of human pneumonia. Am J Physiol Lung Cell Mol Physiol 2008; 294: L387-L398.
38. Hutchinson J, Fogarty A, Hubbard R, et al., Global incidence and mortality of idiopathic pulmonary fibrosis: a systematic review. Eur Respir J 2015; 46: 795-806.
39. Raghu G, Rochwerg B, Zhang Y, et al., An official ATS/ERS/JRS/ALAT clinical practice guideline: treatment of idiopathic pulmonary fibrosis. An update of the 2011 clinical practice guideline. Am J Respir Crit Care Med 2011; 192: e3-e19.
40. Gharaee-Kermani M, Gyetko MR, Hu B, et al., New insights into the pathogenesis and treatment of idiopathic pulmonary fibrosis: a potential role for stem cells in the lung parenchyma and implications for therapy. Pharm Res 2007; 24: 819-841.
41. Hambly N, Shimbori C, Kolb M,. Molecular classification of idiopathic pulmonary fibrosis: personalized medicine, genetics and biomarkers. Respirology 2015; 20: 1010-1022.
42. Richeldi L, du Bois RM, Raghu G, et al., Efficacy and safety of nintedanib in idiopathic pulmonary fibrosis. N Engl J Med 2014; 370: 2071-2082.
43. King TE Jr, Bradford WZ, Castro-Bernardini S, et al., A phase 3 trial of pirfenidone in patients with idiopathic pulmonary fibrosis. N Engl J Med 2014; 370: 2083-2092.
44. Moore BB, Hogaboam CM,. Murine models of pulmonary fibrosis. Am J Physiol Lung Cell Mol Physiol 2008; 294: L152-L160.
45. Moeller A, Ask K, Warburton D, et al., The bleomycin animal model: a useful tool to investigate treatment options for idiopathic pulmonary fibrosis? Int J Biochem Cell Biol 2008; 40: 362-382.
46. Bagnato G, Bitto A, Pizzino G, et al., Simvastatin attenuates the development of pulmonary and cutaneous fibrosis in a murine model of systemic sclerosis. Rheumatology (Oxford) 2013; 52: 1377-1386.
47. Holmes AM, Solari R, Holgate ST,. Animal models of asthma: value, limitations and opportunities for alternative approaches. Drug Discov Today 2011; 16: 659-670.
48. Alderton WK, Angell AD, Craig C, et al., GW274150 and GW273629 are potent and highly selective inhibitors of inducible nitric oxide synthase in vitro and in vivo. Br J Pharmacol 2005; 145: 301-312.
49. Sisson TH, Mendez M, Choi K, et al., Targeted injury of type II alveolar epithelial cells induces pulmonary fibrosis. Am J Respir Crit Care Med 2010; 181: 254-263.
50. Sime PJ, Xing Z, Graham FL, et al., Adenovector-mediated gene transfer of active transforming growth factor-β1 induces prolonged severe fibrosis in rat lung. J Clin Invest 1997; 100: 768-776.
51. Liu Y, Zhang S, Li DW, et al., Efficacy of anti-interleukin-5 therapy with mepolizumab in patients with asthma: a meta-analysis of randomized placebo-controlled trials. PLoS One 2013; 8: e59872.
52. Nials AT, Uddin S,. Mouse models of allergic asthma: acute and chronic allergen challenge. Dis Model Mech 2008; 1: 213-220.
53. Riley JP, Fuchs B, Sjoberg L, et al., Mast cell mediators cause early allergic bronchoconstriction in guinea-pigs in vivo: a model of relevance to asthma. Clin Sci (Lond) 2013; 125: 533-542.
54. Skoglund P, Ersmark E, Palkopoulou E, et al., Ancient wolf genome reveals an early divergence of domestic dog ancestors and admixture into high-latitude breeds. Curr Biol 2015; 25: 1515-1519.
55. Driscoll CA, Menotti-Raymond M, Roca AL, et al., The Near Eastern origin of cat domestication. Science 2007; 317: 519-523.
56. Axelsson E, Ratnakumar A, Arendt ML, et al., The genomic signature of dog domestication reveals adaptation to a starch-rich diet. Nature 2013; 495: 360-364.
57. Montague MJ, Li G, Gandolfi B, et al., Comparative analysis of the domestic cat genome reveals genetic signatures underlying feline biology and domestication. Proc Natl Acad Sci USA 2014; 111: 17230-17235.
58. Heikkila-Laurila HP, Rajamaki MM,. Idiopathic pulmonary fibrosis in West Highland white terriers. Vet Clin North Am Small Anim Pract 2014; 44: 129-142.
59. Williams K, Malarkey D, Cohn L, et al., Identification of spontaneous feline idiopathic pulmonary fibrosis: morphology and ultrastructural evidence for a type II pneumocyte defect. Chest 2004; 125: 2278-2288.
60. Cohn LA, Norris CR, Hawkins EC, et al., Identification and characterization of an idiopathic pulmonary fibrosis-like condition in cats. J Vet Intern Med 2004; 18: 632-641.
61. Miele A, Dhaliwal K, Du Toit N, et al., Chronic pleuropulmonary fibrosis and elastosis of aged donkeys: similarities to human pleuroparenchymal fibroelastosis. Chest 2014; 145: 1325-1332.
62. American Thoracic Society. Idiopathic pulmonary fibrosis: diagnosis and treatment. International consensus statement. American Thoracic Society (ATS), and the European Respiratory Society (ERS). Am J Respir Crit Care Med 2000; 161: 646-664.
63. American Thoracic Society/European Respiratory Society International Multidisciplinary Consensus Classification of the Idiopathic Interstitial Pneumonias. This joint statement of the American Thoracic Society (ATS), and the European Respiratory Society (ERS) was adopted by the ATS board of directors, June 2001 and by the ERS Executive Committee, June 2001. Am J Respir Crit Care Med 2002; 165: 277-304.
64. Corcoran BM, Cobb M, Martin MW, et al., Chronic pulmonary disease in West Highland white terriers. Vet Rec 1999; 144: 611-616.
65. Norris AJ, Naydan DK, Wilson DW,. Interstitial lung disease in West Highland White Terriers. Vet Pathol 2005; 42: 35-41.
66. Webb JA, Armstrong J,. Chronic idiopathic pulmonary fibrosis in a West Highland white terrier. Can Vet J 2002; 43: 703-705.
67. Heikkila-Laurila HP, Rajamaki MM,. Idiopathic pulmonary fibrosis in West Highland white terriers. Vet Clin North Am Small Anim Pract 2014; 44: 129-142.
68. Heikkila HP, Lappalainen AK, Day MJ, et al., Clinical, bronchoscopic, histopathologic, diagnostic imaging, and arterial oxygenation findings in West Highland White Terriers with idiopathic pulmonary fibrosis. J Vet Intern Med 2011; 25: 433-439.
69. Lilja-Maula LI, Laurila HP, Syrja P, et al., Long-term outcome and use of 6-minute walk test in West Highland White Terriers with idiopathic pulmonary fibrosis. J Vet Intern Med 2014; 28: 379-385.
70. Heikkila HP, Lappalainen AK, Day MJ, et al., Clinical, bronchoscopic, histopathologic, diagnostic imaging, and arterial oxygenation findings in West Highland White Terriers with idiopathic pulmonary fibrosis. J Vet Intern Med 2011; 25: 433-439.
71. Syrja P, Heikkila HP, Lilja-Maula L, et al., The histopathology of idiopathic pulmonary fibrosis in West Highland white terriers shares features of both non-specific interstitial pneumonia and usual interstitial pneumonia in man. J Comp Pathol 2013; 149: 303-313.
72. Lilja-Maula LI, Palviainen MJ, Heikkila HP, et al., Proteomic analysis of bronchoalveolar lavage fluid samples obtained from West Highland White Terriers with idiopathic pulmonary fibrosis, dogs with chronic bronchitis, and healthy dogs. Am J Vet Res 2013; 74: 148-154.
73. Lilja-Maula L, Syrja P, Laurila HP, et al., Comparative study of transforming growth factor-beta signalling and regulatory molecules in human and canine idiopathic pulmonary fibrosis. J Comp Pathol 2014; 150: 399-407.
74. Krafft E, Lybaert P, Roels E, et al., Transforming growth factor β1 activation, storage, and signaling pathways in idiopathic pulmonary fibrosis in dogs. J Vet Intern Med 2014; 28: 1666-1675.
75. Khalil N, O'Connor RN, Flanders KC, et al., TGF-beta 1, but not TGF-beta 2 or TGF-beta 3, is differentially present in epithelial cells of advanced pulmonary fibrosis: an immunohistochemical study. Am J Respir Cell Mol Biol 1996; 14: 131-138.
76. Khalil N, O'Connor RN, Unruh HW, et al., Increased production and immunohistochemical localization of transforming growth factor-beta in idiopathic pulmonary fibrosis. Am J Respir Cell Mol Biol 1991; 5: 155-162.
77. Roels E, Krafft E, Antoine N, et al., Evaluation of chemokines CXCL8 and CCL2, serotonin, and vascular endothelial growth factor serum concentrations in healthy dogs from seven breeds with variable predisposition for canine idiopathic pulmonary fibrosis. Res Vet Sci 2015; 101: 57-62.
78. Roels E, Krafft E, Farnir F, et al., Assessment of CCL2 and CXCL8 chemokines in serum, bronchoalveolar lavage fluid and lung tissue samples from dogs affected with canine idiopathic pulmonary fibrosis. Vet J 2015; 206: 75-82.
79. Cohn LA NC, Hawkins EC, Dye JA, et al., Identification and characterization of an idiopathic pulmonary fibrosis-like condition in cats. J Vet Intern Med 2004; 18: 632-641.
80. Evola MG, Edmondson EF, Reichle JK, et al., Radiographic and histopathologic characteristics of pulmonary fibrosis in nine cats. Vet Radiol Ultrasound 2014; 55: 133-140.
81. Williams KJ, Maes R, Del Piero F, et al., Equine multinodular pulmonary fibrosis: a newly recognized herpesvirus-associated fibrotic lung disease. Vet Pathol 2007; 44: 849-862.
82. Williams KJ, Robinson NE, Lim A, et al., Experimental induction of pulmonary fibrosis in horses with the gammaherpesvirus equine herpesvirus 5. PLoS One 2013; 8: e77754.
83. Lok SS, Egan JJ,. Viruses and idiopathic pulmonary fibrosis. Monaldi Arch Chest Dis 2000; 55: 146-150.
84. Vannella KM, Moore BB,. Viruses as co-factors for the initiation or exacerbation of lung fibrosis. Fibrogenesis Tissue Repair 2008; 1: 2.
85. Arase Y, Suzuki F, Suzuki Y, et al., Hepatitis C virus enhances incidence of idiopathic pulmonary fibrosis. World J Gastroenterol 2008; 14: 5880-5886.
86. Ueda T, Ohta K, Suzuki N, et al., Idiopathic pulmonary fibrosis and high prevalence of serum antibodies to hepatitis C virus. Am Rev Respir Dis 1992; 146: 266-268.
87. Kuwano K, Nomoto Y, Kunitake R, et al., Detection of adenovirus E1A DNA in pulmonary fibrosis using nested polymerase chain reaction. Eur Respir J 1997; 10: 1445-1449.
88. Dworniczak S, Ziora D, Kapral M, et al., Human cytomegalovirus DNA level in patients with idiopathic pulmonary fibrosis. J Physiol Pharmacol 2004; 55 (Suppl 3): 67-75.
89. Kelly BG, Lok SS, Hasleton PS, et al., A rearranged form of Epstein-Barr virus DNA is associated with idiopathic pulmonary fibrosis. Am J Respir Crit Care Med 2002; 166: 510-513.
90. Stewart JP, Egan JJ, Ross AJ, et al., The detection of Epstein-Barr virus DNA in lung tissue from patients with idiopathic pulmonary fibrosis. Am J Respir Crit Care Med 1999; 159: 1336-1341.
91. Tang YW, Johnson JE, Browning PJ, et al., Herpesvirus DNA is consistently detected in lungs of patients with idiopathic pulmonary fibrosis. J Clin Microbiol 2003; 41: 2633-2640.
92. Pulkkinen V, Salmenkivi K, Kinnula VL, et al., A novel screening method detects herpesviral DNA in the idiopathic pulmonary fibrosis lung. Ann Med 2012; 44: 178-186.
93. Wangoo A, Shaw RJ, Diss TC, et al., Cryptogenic fibrosing alveolitis: lack of association with Epstein-Barr virus infection. Thorax 1997; 52: 888-891.
94. Bell SA, Balasuriya UB, Gardner IA, et al., Temporal detection of equine herpesvirus infections of a cohort of mares and their foals. Vet Microbiol 2006; 116: 249-257.
95. Wang L, Raidal SL, Pizzirani A, et al., Detection of respiratory herpesviruses in foals and adult horses determined by nested multiplex PCR. Vet Microbiol 2007; 121: 18-28.
96. Wong DM, Belgrave RL, Williams KJ, et al., Multinodular pulmonary fibrosis in five horses. J Am Vet Med Assoc 2008; 232: 898-905.
97. Morrow LD, Smith KC, Piercy RJ, et al., Retrospective analysis of post-mortem findings in 1,444 aged donkeys. J Comp Pathol 2011; 144: 145-156.
98. Miele A, Dhaliwal K, Du Toit N, et al., Chronic pleuropulmonary fibrosis and elastosis of aged donkeys: similarities to human pleuroparenchymal fibroelastosis. Chest 2014; 145: 1325-1332.
99. Travis WD, Costabel U, Hansell DM, et al., An official American Thoracic Society/European Respiratory Society statement: update of the international multidisciplinary classification of the idiopathic interstitial pneumonias. Am J Respir Crit Care Med 2013; 188: 733-748.
100. Frankel SK, Cool CD, Lynch DA, et al., Idiopathic pleuroparenchymal fibroelastosis: description of a novel clinicopathologic entity. Chest 2004; 126: 2007-2013.
101. Reddy TL, Tominaga M, Hansell DM, et al., Pleuroparenchymal fibroelastosis: a spectrum of histopathological and imaging phenotypes. Eur Respir J 2012; 40: 377-385.
102. von der Thusen JH,. Pleuroparenchymal fibroelastosis: its pathological characteristics. Curr Respir Med Rev 2013; 9: 238-247.
103. Pirie RS,. Recurrent airway obstruction: a review. Equine Vet J 2014; 46: 276-288.
104. Bullone M, Lavoie JP,. Asthma 'of horses and men'-how can equine heaves help us better understand human asthma immunopathology and its functional consequences? Mol Immunol 2015; 66: 97-105.
105. Reinero CR,. Advances in the understanding of pathogenesis, and diagnostics and therapeutics for feline allergic asthma. Vet J 2011; 190: 28-33.
106. Trzil JE, Reinero CR,. Update on feline asthma. Vet Clin North Am Small Anim Pract 2014; 44: 91-105.
107. Reinero CR, DeClue AE, Rabinowitz P,. Asthma in humans and cats: is there a common sensitivity to aeroallegens in shared environments? Environ Res 2009; 109: 634-640.
108. Hotchkiss JW, Reid SW, Christley RM,. A survey of horse owners in Great Britain regarding horses in their care. Part 2: Risk factors for recurrent airway obstruction. Equine Vet J 2007; 39: 301-308.
109. Tesarowski DB, Viel L, McDonell WN,. Pulmonary function measurements during repeated environmental challenge of horses with recurrent airway obstruction (heaves). Am J Vet Res 1996; 57: 1214-1219.
110. Clarke AF, Madelin T,. Technique for assessing respiratory health hazards from hay and other source materials. Equine Vet J 1987; 19: 442-447.
111. Jean D, Vrins A, Beauchamp G, et al., Evaluation of variations in bronchoalveolar lavage fluid in horses with recurrent airway obstruction. Am J Vet Res 2011; 72: 838-842.
112. Gerber V, Robinson NE, Venta RJ, et al., Mucin genes in horse airways: MUC5AC, but not MUC2, may play a role in recurrent airway obstruction. Equine Vet J 2003; 35: 252-257.
113. Jefcoat AM, Hotchkiss JA, Gerber V, et al., Persistent mucin glycoprotein alterations in equine recurrent airway obstruction. Am J Physiol Lung Cell Mol Physiol 2001; 281: L704-L712.
114. Venema CM, Patterson CC,. Feline asthma: what's new and where might clinical practice be heading? J Feline Med Surg 2010; 12: 681-692.
115. Corcoran BM, Foster DJ, Fuentes VL,. Feline asthma syndrome: a retrospective study of the clinical presentation in 29 cats. J Small Anim Pract 1995; 36: 481-488.
116. Dye JA, McKiernan BC, Rozanski EA, et al., Bronchopulmonary disease in the cat: historical, physical, radiographic, clinicopathologic, and pulmonary functional evaluation of 24 affected and 15 healthy cats. J Vet Intern Med 1996; 10: 385-400.
117. Cohn L, Elias JA, Chupp GL,. Asthma: mechanisms of disease persistence and progression. Annu Rev Immunol 2004; 22: 789-815.
118. Hunninghake GW, Schwarz MI,. Does current knowledge explain the pathogenesis of idiopathic pulmonary fibrosis? A perspective. Proc Am Thorac Soc 2007; 4: 449-452.